Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF CASH FLOWS

v3.21.2
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:    
Net loss $ (2,818) $ (4,158)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share based compensation 299 592
Changes in operating assets and liabilities:    
Other receivables - related party (74) 0
Prepaid expenses and other current assets 84 143
Accounts payable and accrued expenses (185) (14)
Accounts payable and accrued expenses - related party 147 17
Net cash and cash equivalents used in operating activities (2,547) (3,420)
Cash flows from investing activities:    
Milestone payment for research and development licenses 0 (1,000)
Net cash and cash equivalents used in investing activities 0 (1,000)
Net change in cash and cash equivalents (2,547) (4,420)
Cash and cash equivalents, beginning of period 3,132 8,745
Cash and cash equivalents, end of period $ 585 $ 4,325